Literature DB >> 17570232

Nuclear factor-kappaB in the liver: friend or foe?

Robert F Schwabe, David A Brenner.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17570232     DOI： 10.1053/j.gastro.2007.04.058

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

2.  Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion.

Authors:  Yanjun Shi; Hasibur Rehman; Venkat K Ramshesh; Justin Schwartz; Qinlong Liu; Yasodha Krishnasamy; Xun Zhang; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

3.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Nuclear factor kappa B signaling either stimulates or inhibits neurite growth depending on the phosphorylation status of p65/RelA.

Authors:  Humberto Gutierrez; Gerard W O'Keeffe; Núria Gavaldà; Denis Gallagher; Alun M Davies
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

5.  Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines.

Authors:  Laura Cesaratto; Erika Codarin; Carlo Vascotto; Antonio Leonardi; Mark R Kelley; Claudio Tiribelli; Gianluca Tell
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.